Clostridium difficile and inflammatory bowel disease: More questions than answers?

Inflammatory Bowel Diseases

Volumn 16, Issue 8, 2010, Pages 1445-1446

  Ananthakrishnan, Ashwin N ^a   Binion, David G ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; HYPERTENSIVE FACTOR; IMMUNOMODULATING AGENT; MERCAPTOPURINE; METHOTREXATE; METRONIDAZOLE; PREDNISONE; TACROLIMUS;

CLOSTRIDIUM DIFFICILE; DISEASE EXACERBATION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATORY DISEASE; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

EID: 77955729162     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21140     Document Type: Note

References (7)

1. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57:205-210. (Pubitemid 351158048)
2. Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345-351. (Pubitemid 46401531)
3. Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339-344. (Pubitemid 46401530)
4. Bossuyt P, Verhaegen J, Van Assche G, et al. Increasing incidence of Clostridium difficile-assiociated diarrhea in inflammatory bowel disease. J Crohns Colitis. 2009;3:4-7.
5. Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443-1450.
6. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci. 2009 [Epub ahead of print].
7. Chiplunker A, Ananthakrishnan AN, Beaulieu DB, et al. Long-term impact of Clostridium difficile on inflammatory bowel disease. Gastroenterology. 2009;136(Suppl 1):S1145.